Press Releases

Apr 25, 2022 7:00am EDT

CollPlant CEO Yehiel Tal to Moderate ISBF's virtual event on Biofabrication of Microphysiological Systems for Drug Discovery and Screening

Apr 13, 2022 7:00am EDT

CollPlant To Present at the Aesthetics Innovation Summit 2022

Mar 24, 2022 7:00am EDT

CollPlant Biotechnologies Provides Business Updates and Fiscal Year 2021 Financial Results

Feb 16, 2022 8:00am EST

CELLINK and CollPlant Enter a Collaboration Agreement to Explore Future Large-Scale Production of CollPlant's Regenerative Breast Implants using CELLINK's Bioprinting technologies

Jan 05, 2022 7:00am EST

CollPlant Issues Letter to Shareholders

Dec 02, 2021 7:00am EST

CollPlant Announces Publication Highlighting its rhCollagen-based Photocurable Dermal Filler in the Plastic and Reconstructive Surgery Journal

Nov 18, 2021 7:00am EST

CollPlant Biotechnologies Provides Business Updates and Third Quarter 2021 Financial Results

Nov 15, 2021 7:00am EST

CollPlant Announces Commercial Launch of BioInk Platform with Collink.3D™ for Use in 3D Bioprinting of Human Tissues, Scaffolds and Organs

Oct 14, 2021 7:00am EDT

CollPlant to Present at Dawson James Small Cap Growth Conference on October 21st

Oct 11, 2021 7:00am EDT

CollPlant's rhCollagen BioInk Used by Technion Researchers to Develop 3D Bioprinted Vascularized Tissue Constructs